Skip to main content
. Author manuscript; available in PMC: 2015 Feb 12.
Published in final edited form as: Future Oncol. 2014 May;10(7):1277–1297. doi: 10.2217/fon.13.271

Table 1.

Imaging changes after radiation therapy.

Parameter Pseudoprogression Treatment effect after radiosurgery Radionecrosis Tumor progression
Time to onset 2–6 months after RT 3–12 months after RT 6–12 months after RT (but can be decades) Any
Characteristic imaging appearance Contrast enhancement with FLAIR hyperintensity Contrast enhancement with FLAIR hyperintensity Contrast enhancement with FLAIR hyperintensity; ‘soap bubble’ or ‘Swiss cheese’ sign Contrast enhancement with FLAIR hyperintensity
Treatment Observation with close follow-up Observation with close follow-up Steroids, bevacizumab, surgical resection Tumor-directed therapy
Usually symptomatic? No No Yes Yes
MRI spectroscopy Not clearly radionecrosis or tumor progression Not clearly radionecrosis or tumor progression Relatively less choline Relatively less NAA and creatine; more choline and lactate
Diffusion weighted imaging Not clearly radionecrosis or tumor progression Not clearly radionecrosis or tumor progression Less restricted diffusion (lower signal) More restricted diffusion (higher signal)
Dynamic contrast imaging Relatively low mean cerebral blood volume compared with true tumor progression Relatively low mean cerebral blood volume compared with true tumor progression Relatively low mean cerebral blood volume compared with true tumor progression Relatively high mean cerebral blood volume

FLAIR: Fluid attenuated inversion recovery; RT: Radiation therapy.